The <i>BRCA2</i> c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity
Mara Colombo, Henrik Flyger(University of Copenhagen), E. Gómez(Maastricht University Medical Centre), Volker Arndt(German Cancer Research Center), Angela Cox, Hiltrud Brauch(German Cancer Research Center), Natalia Bogdanova(Medizinische Hochschule Hannover), Fergus J. Couch(Mayo Clinic), Peter A. Fasching(Universitätsklinikum Erlangen), Raquel Behar(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Jenny Chang‐Claude(Universität Hamburg), Simon S. Cross(University of Sheffield), Thilo Dörk(Hannover Re (Germany)), Jonine D. Figueroa, Bernardo Bonanni(European Institute of Oncology), Huong Meeks(University of Utah), Joe Dennis(University of Cambridge), Ane Yde Schmidt(University of Copenhagen), Siranoush Manoukian(Fondazione IRCCS Istituto Nazionale dei Tumori), Mikael Eriksson(Herlev Hospital), Kamila Czene(Karolinska Institutet), Michael T. Parsons, Marco Montagna(Azienda Ospedale - Università Padova), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Peter Devilee(Leiden University), Liliana Varesco(Istituti di Ricovero e Cura a Carattere Scientifico), Emma Tudini(QIMR Berghofer Medical Research Institute), Irene L. Andrulis(University of Toronto), Javier Benı́tez(Spanish National Cancer Research Centre), Laura Caleca, P Mondini(Fondazione IRCCS Istituto Nazionale dei Tumori), Olivia Fletcher(Breast Cancer Care), Stig E. Bojesen(University of Copenhagen), Hermann Brenner(Universidad de Granada), Dieter Niederacher(Heinrich Heine University Düsseldorf), Hoda Anton‐Culver(University of California, Irvine), Bram Boeckx(VIB-KU Leuven Center for Cancer Biology), Irene López‐Perolio(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Don Conroy(University of Cambridge), Alicia Beeghly-Fadel(Vanderbilt University), Qin Wang(University of Cambridge), Hongyan Li(Liaoning Normal University), Barbara Wappenschmidt(University Hospital Cologne), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, Kristiina Aittomäki(University of Helsinki), Giovanna De Vecchi(IFOM), Manjeet K. Bolla(University of Cambridge), Claudia Foglia(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 20
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k